Key facts
- This page summarizes Greg Jensen's Form 4 filing for Xtant Medical Holdings, Inc. (XTNT).
- 2 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 17 Aug 2021, 16:20.
Greg Jensen - 15 Aug 2021 Form 4 Insider Report for Xtant Medical Holdings, Inc. (XTNT)
- Reporting relationship
- Vice President, Finance & CFO
- Issuer ticker
- XTNT
- Reported as of
- 15 Aug 2021
- Net transaction value
- $0
- Reporting owner signature
- /s/ Amy Culbert, attorney-in-fact
Source evidence
Original filing metadata and source links for verification.
3 source fields
Reporting owner
1 detail
Key filing fact
Greg Jensen filed Form 4 for Xtant Medical Holdings, Inc. (XTNT) on 17 Aug 2021.
Change
- No earlier filing in this sequence is available for direct comparison.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
XTNT
transaction
Common Stock, $0.000001 par value
Award
- Transaction value
- $0
- Shares
- +156,250
- Change %
- +121%
- Price
- $0.000000
- Shares after
- 285,331
- Date
- 15 Aug 2021
- Ownership
- Direct
- Footnotes
- F1, F2
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
XTNT
transaction
Derivative
Stock Option (right to buy)
Award
- Transaction value
- $0
- Shares
- +192,308
- Change %
- Price
- $0.000000
- Shares after
- 192,308
- Date
- 15 Aug 2021
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 192,308
- Exercise price
- $1.27
- Footnotes
- F3
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 3 footnotes
Footnote F1
These shares will vest and be issued with respect to 39,062 shares on each of August 15, 2022, August 15, 2023 and August 15, 2024 and with respect to 39,064 shares on August 15, 2025 pursuant to a restricted stock unit granted under the Xtant Medical Holdings, Inc. 2018 Equity Incentive Plan.
Footnote F2
Includes 244,587 shares that will be issued over time subject to vesting pursuant to restricted stock units granted under the Xtant Medical Holdings, Inc. 2018 Equity Incentive Plan.
Footnote F3
This option vests with respect to 48,077 shares on August 15, 2021 and with respect to the remaining 75% of such shares over the three-year period thereafter in 12 as nearly equal as possible quarterly installments, subject to such Reporting Person's continued employment with Xtant Medical Holdings, Inc.